Sign in

CIK 0000885590

  • Large accelerated filer

Bausch Health Companies Inc.

Sign in to watch
Ticker
BHC
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NJ
Entity type
Operating
Phone
+1 514-744-6792
Business address
2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
Former names
Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
  1. 4 Grant or award Director acquired 3,896 shares (grant or award)
  2. 4 Grant or award Director acquired 4,130 shares (grant or award)
  3. 4 Grant or award Director acquired 7,793 shares (grant or award)
  4. 4 Grant or award Director acquired 857 shares (grant or award)
  5. 4 Planned sale EVP, General Counsel sold 220 shares at $7.38 ($1,624)
  6. 4 Planned sale EVP, General Counsel sold 43 shares at $7.61 ($327)
  7. 4 Grant or award Director acquired 836 shares (grant or award)
  8. 4 Grant or award Director acquired 3,801 shares (grant or award)
  9. 4 Grant or award Director acquired 7,603 shares (grant or award)
  10. 4 Grant or award Director acquired 4,029 shares (grant or award)
  11. 4 Planned sale EVP, General Counsel sold 6,685 shares at $8.28 ($55,352)
  12. 4 Shares withheld for taxes SVP, Controller & CAO gave up 3,982 shares (to pay taxes)
  13. 4 Shares withheld for taxes EVP, Chief Financial Officer gave up 43,948 shares (to pay taxes)
  14. 4 Shares withheld for taxes Chief Executive Officer gave up 14,111 shares (to pay taxes)
  15. 4 Grant or award Director acquired 859 shares (grant or award)
  16. 4 Grant or award Director acquired 4,140 shares (grant or award)
  17. 4 Grant or award Director acquired 7,812 shares (grant or award)
  18. 4 Grant or award Director acquired 3,906 shares (grant or award)
  19. 4 Shares withheld for taxes SVP, Controller & CAO gave up 1,929 shares (to pay taxes)
  20. 4 Grant or award Director acquired 29,205 shares (grant or award)

Page 7 of 61 · 1,214 filings